![]() |
市場調查報告書
商品編碼
1800962
氣道正壓通氣設備市場報告(按產品類型(自動氣道正壓通氣設備、持續性氣道正壓通氣設備、雙水平氣道正壓通氣設備)、最終用戶和地區,2025 年至 2033 年)Positive Airway Pressure Devices Market Report by Product Type (Automatic Positive Airway Pressure Devices, Continuous Positive Airway Pressure Devices, Bi-level Positive Airway Pressure Devices), End User, and Region 2025-2033 |
2024年,全球正氣道壓力設備市場規模達38億美元。展望未來, IMARC Group預計到2033年,該市場規模將達到61億美元,2025-2033年期間的複合年成長率(CAGR)為5.14%。憂鬱症、高血壓、糖尿病和心臟病的發生率不斷上升,刺激著市場的發展。
睡眠呼吸中止症盛行率不斷上升
人們對睡眠障礙的認知不斷提高,診斷和治療的需求也隨之增加,從而促進了市場的發展。例如,荷蘭醫療保健公司飛利浦於2024年5月推出了用於治療睡眠呼吸中止症的持續性正壓呼吸器(CPAP)治療設備。此外,在印度,飛利浦透過熱線和網站提供支援。這為氣道正壓通氣設備的市場前景做出了貢獻。
不斷進步的技術
持續的創新正在刺激市場發展,例如提升治療效果、根據使用者需求自動調節壓力水平、提升患者舒適度等。此外,面罩設計的進步,旨在最大限度地降低噪音,也推動了整體市場的發展。 2024年7月,先前以製氧機解決方案聞名的Varon推出了全新的Sunnygrand系列,該系列產品可與醫生的處方設定和治療方案相結合,為睡眠呼吸中止症患者提供有效舒適的治療。它還支持醫護人員的持續監測和調整。根據氣道正壓通氣設備市場分析報告,這正成為重要的成長誘因。
家庭醫療保健需求不斷成長
隨著醫療成本的不斷上漲以及以患者為中心的照護日益受到重視,越來越多的人選擇居家管理睡眠呼吸中止症。這使得醫療保健提供者能夠遠端監控和調整治療方案。 2024年3月,React Health 開發了一款名為 Luna TravelPAP 的旅行型 CPAP。它是一款小巧輕便的正壓通氣裝置,具有 CPAP 和 AutoCPAP 模式。此外,它還具有供氣提醒、可選便攜包、指示燈等功能。
The global positive airway pressure devices market size reached USD 3.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.1 Billion by 2033, exhibiting a growth rate (CAGR) of 5.14% during 2025-2033. The increasing occurrence of depression, hypertension, diabetes, and heart disorders is stimulating the market.
Increasing Prevalence of Sleep Apnea
The rising awareness towards the occurrence of sleep disorders is escalating the demand for diagnosis and treatment, which is catalyzing the market. For example, in May 2024, Dutch healthcare company Philips launched continuous positive airway pressure (CPAP) therapy devices that are used to treat sleep apnea. Moreover, in India, Philips offered support through a hotline and website. This is contributing to the positive airway pressure devices market outlook.
Rising Technological Advancements
Continuous innovations, which enhance treatment efficacy, automatically adjust pressure levels based on the user's needs, elevate patient comfort, etc., are stimulating the market. Furthermore, advances in mask design with features aimed at minimizing noise are also propelling the overall market. In July 2024, Varon, previously known for oxygen concentrator solutions, introduced its new Sunnygrand series that offer effective and comfortable treatment for sleep apnea patients, integrating with doctors' prescribed settings and therapy plans. It also supports ongoing monitoring and adjustments by healthcare professionals. As per the positive airway pressure devices market analysis report, it is acting as a significant growth-inducing factor.
Escalating Demand for Home Healthcare
With the inflating healthcare costs and the increasing emphasis on patient-centric care, more individuals are opting for home-based management of sleep apnea. It allows healthcare providers to monitor and adjust treatment remotely. In March 2024, React Health developed a travel CPAP called the Luna TravelPAP. It is a small, lightweight positive airway pressure device with CPAP and AutoCPAP modes. Additionally, it has supply reminders, an optional carrying case, a light ring indicator, etc.
Continuous positive airway pressure (CPAP) devices dominate the total positive airway pressure devices market share
The inflating requirement for enhanced user comfort and treatment efficacy is driving the segment's growth. For example, the development of ResMed's AirSense 11, which features an auto-adjusting algorithm and integrated connectivity that enables personalized therapy adjustments and remote monitoring.
Hospitals and sleep labs hold the majority of the global positive airway pressure devices market demand
In these clinical settings, advanced PAP devices are utilized to ensure accurate diagnosis and effective treatment. For example, the Philips Respironics DreamStation BiPAP AutoSV is frequently adopted in hospitals for patients with complex sleep apnea, owing to its ability to adjust pressure levels automatically based on the patient's needs. This is expanding the positive airway pressure devices market forecast report.
North America exhibits a clear dominance in the market
The positive airway pressure devices market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
The widespread prevalence of sleep apnea and other respiratory disorders is augmenting the positive airway pressure devices market outlook report in North America. In February 2024, ResMed introduced its AirCurve 11 series bilevel positive airway pressure devices in the U.S. It is designed to help providers treat sleep apnea while patients start and stay on therapy.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include: